American consumers pay hundreds of billion of dollars in inflated pharmaceutical prices because drug companies are legal monopolies, a result of current patent laws. Dean Baker of the Center for Economic and Policy Research evaluates 4 separate strategies for slashing the cost of drugs and seeing drugs as a common good.
David Morris
David Morris is co-founder of the Institute for Local Self-Reliance and currently ILSR's distinguished fellow. His five non-fiction books range from an analysis of Chilean development to the future of electric power to the transformation of cities and neighborhoods. For 14 years he was a regular columnist for the Saint Paul Pioneer Press. His essays on public policy have appeared in the New York Times, Wall Street Journal, Washington Post, Salon, Alternet, Common Dreams, and the Huffington Post.
Latest posts from David
- Democracy for All: Amending the U.S. Constitution - October 23, 2019
- Americans Voted Directly on Policies As Well As People - November 12, 2018
- New Zealand: Feminist Policies Drive a Progressive Agenda - October 8, 2018